IP Library Assignment 025628/0029
Patent Assignment
Reel/Frame 025628/0029

Assignment of Assignor's Interest

Recorded: 2011-01-12 Pages: 3
Assignor
ALNYLAM EUROPE AG
Executed: 2006-12-13
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property (1)
Compositions and Methods for Inhibiting Expression of NAV1.8 Gene
Patent: 7,902,168 →
Application: 12/487,605 →
Publication: US 2009/0258934
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 12, 2011
From: SAH, DINAH; FRANK-KAMENETSKY, MARIA
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 025628/0006 →
Assignment of Assignor's Interest Jan 12, 2011
From: GEICK, ANKE; HADWIGER, PHILIPP; ROEHL, INGO; TAN, PAMELA
To: ALNYLAM EUROPE AG
Reel/Frame 025628/0022 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →